drugset / Trial / NCT07081659

On-demand Silodosin 4mg vs Dapoxetine 60mg in Treatment of Primary Premature Ejaculation

NCT07081659

Phase 2/3 Completed 95 enrolled Benha University
RandomizedParallel-groupSingle-blindTreatment

Summary

Both Silodosin 4 mg and Dapoxetine 60 mg significantly improved IELT and sexual function scores in primary PE patients. However, Silodosin exhibited a more favorable tolerability profile with fewer side effects, making it a safer, clinically effective alternative.

Timeline

Start
2024-03-01
Primary completion
2024-03-01
Completion
2025-04-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dapoxetine Small molecule 60 mg
Subject Silodosin Unknown 4 mg

Indications